ASKLEPIOS Course. August 24, 2018 Recife/Brazil

Transcription

1 ASKLEPIOS Course This ASKLEPIOS Course is implemented with great support and partnership of Bayer and CBR (Brazilian College of Radiology). Education in partnership

2 ASKLEPIOS Course ASKLEPIOS Course Course information The course is aimed at senior residents, board-certified radiologists and fellows interested in MR imaging and will focus on the most successful technical consideration to acquire high-quality images in oncologic patients. It will further concentrate on the evaluation of updated diagnostic findings, stratifying criteria and staging principles as well as treatment strategies and effects assessment. The clinical role of MR imaging in liver, rectal, renal and prostate cancer will be presented. A special focus will be devoted to the applications of the latest technical advances and newer European guidelines for MR imaging in these oncologic situations. Internationally renowned European and Brazilian experts will ensure a high-quality teaching programme combining plenary lectures and workshops allowing for interactive case discussion. Learning objectives to present an update on the current MR imaging protocols used in oncologic patients for the detection and characterisation of some of the most important and frequent neoplastic diseases of the abdomen to learn more about the imaging features relevant to clinical decision-making in these patients to explain the clinical significance of early tumour detection and the necessity of accurate staging for appropriate therapy-planning and correct estimation of patients prognosis to discuss the role of imaging in therapy monitoring, evaluation of treatment effects, lesions restaging and follow-up of these neoplasms to introduce the new European and international imaging guidelines used for these tumours

3 Programme ASKLEPIOS Course Friday, 08:00 08:45 Registration 08:45 09:00 Welcome and introduction 09:00 09:30 Why MRI is crucial in patients with resectable liver metastases V. Vilgrain, Clichy/FR 09:30 10:00 Hepatocellular carcinoma insights from morphological and biological imaging: a guideline to radiologists L. Marti-Bonmati, Valencia/ES 10:00 10:30 Rectal cancer MR-based management C. Ortega, Sao Paulo/BR 10:30 10:50 Coffee break 10:50 13:00 Workshops (V. Vilgrain, L. Marti-Bonmati, C. Ortega) 13:00 14:00 Lunch break 14:00 14:30 MR technical advances in the field of oncologic imaging N. Papanikolaou, Lisbon/PT 14:30 15:00 Kidney neoplasms what is really important? V.F. Muglia, Ribeirao Preto/BR 15:00 15:30 Advances in MR imaging of prostate D. Regge, Candiolo/IT 15:30 15:50 Coffee break 15:50 18:00 Workshops (N. Papanikolaou, V.F. Muglia, D. Regge) Host Organiser M. de Fátima Aragão Recife/BR Venue Hotel Transamérica Prestige Av. Boa Viagem 420 Recife Brazil Registration fee Early fee ESR/CBR members / residents: BRL 300 (until June 11, 2018) Late fee ESR/CBR members / residents: BRL 350 Non-members: BRL 450 (until August 15, 2018) On-site fee ESR/CBR members / residents: BRL 380 Non-members: BRL 520 For registration information please visit: This ASKLEPIOS Course is implemented with great support and partnership of Bayer and CBR (Brazilian College of Radiology). For further information on the programme and registration please visit

4 ASKLEPIOS Course Learning Objectives Why MRI is crucial in patients with resectable liver metastases V. Vilgrain, Clichy/FR to understand how surgical resectability is defined to be aware of the role of MRI in liver metastases to know the most sensitive MR sequences in liver metastases Hepatocellular carcinoma insights from morphological and biological imaging: a guideline to radiologists L. Marti-Bonmati, Valencia/ES to review the natural history, prognostic phenotypes and treatment opportunities in HCC to critically review key imaging findings in HCC to discuss on the key radiomic indicators to evaluate HCC aggressiveness, predict treatment effect and prognosis phenotypes to understand the role of imaging biomarkers in clinical trials of HCC therapies to summarise the main therapy monitoring criteria Rectal cancer MR-based management C. Ortega, Sao Paulo/BR to discuss the role of MR imaging in primary staging to identify the imaging patterns after neoadjuvant treatment to recognise the information that should be included in the report MR technical advances in the field of oncologic imaging N. Papanikolaou, Lisbon/PT to review the basic theoretical and technical aspects behind advanced MRI techniques to discuss the clinical yield of diffusion and perfusion MRI techniques for oncological applications to summarise advances in the field of computational imaging and radiomics Kidney neoplasms what is really important? V.F. Muglia, Ribeirao Preto/BR to understand the optimised protocol for imaging renal masses to analyse the important MRI findings for renal masses characterisation to review the evidence-based MRI algorithm for approaching renal masses Advances in MR imaging of prostate D. Regge, Candiolo/IT to present advances in MRI technique for prostate imaging to summarise the role of MRI in the diagnosis of prostate cancer to review current PIRADS guidelines to assess the role of multiparametric MRI in the staging of prostate cancer This ASKLEPIOS Course is implemented with great support and partnership of Bayer and CBR (Brazilian College of Radiology).

5

6 Please note that programmes are marked with a logo to indicate their classification according to the European Training Curriculum. First three years of training Fourth and fifth year of training (general radiologist standard) Subspecialty training standard ESOR stands for education in partnership. This ASKLEPIOS Course is implemented with great support and partnership of Bayer and CBR (Brazilian College of Radiology).